The Tokyo district court ordered the Japanese government and three drug manufacturers to pay $2.2 million to 13 people who contracted hepatitis from a blood-clotting product used mostly in the 1980s.
Published in Brief:
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Sr. Business Systems Analyst||
|Sr. Reimbursement Analyst||
Olympus America Inc.
|Leadership Recruiting Manager||
|Strategic Partner Relationship Executive||
Geisinger Health System